Tilray (NASDAQ:TLRY) Sets New 1-Year Low at $2.32

Tilray Inc (NASDAQ:TLRY – Get Rating) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $2.32 and last traded at $2.35, with a volume of 1930960 shares changing hands. The stock had previously closed at $2.40.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Atb Cap Markets reiterated a “sector perform” rating on shares of Tilray in a report on Thursday, February 9th. Alliance Global Partners decreased their target price on Tilray from $4.00 to $3.00 and set a “neutral” rating on the stock in a research report on Monday, January 9th. Two analysts have rated the stock with a sell rating and six have issued a hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $4.72.

Tilray Stock Performance

The firm has a 50 day moving average of $2.92 and a two-hundred day moving average of $3.23. The stock has a market cap of $1.59 billion, a PE ratio of -2.46 and a beta of 2.70. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.91 and a quick ratio of 1.35.

Tilray (NASDAQ:TLRY – Get Rating) last issued its quarterly earnings data on Monday, January 9th. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). Tilray had a negative net margin of 89.96% and a negative return on equity of 5.10%. The firm had revenue of $144.10 million during the quarter, compared to analysts’ expectations of $157.21 million. The company’s quarterly revenue was down 7.1% compared to the same quarter last year. Research analysts predict that Tilray Inc will post -0.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Tilray

Large investors have recently modified their holdings of the stock. Macquarie Group Ltd. raised its stake in shares of Tilray by 188.8% during the second quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock worth $27,000 after purchasing an additional 5,583 shares during the last quarter. Activest Wealth Management raised its stake in shares of Tilray by 5,982.4% during the third quarter. Activest Wealth Management now owns 9,306 shares of the company’s stock worth $26,000 after purchasing an additional 9,153 shares during the last quarter. Coastal Investment Advisors Inc. acquired a new position in Tilray during the third quarter worth $28,000. Sutton Place Investors LLC acquired a new position in Tilray during the fourth quarter worth $27,000. Finally, Benedetti & Gucer Inc. acquired a new position in Tilray during the fourth quarter worth $27,000. Hedge funds and other institutional investors own 11.59% of the company’s stock.

About Tilray

(Get Rating)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.